Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)26.37
  • Today's Change-0.35 / -1.31%
  • Shares traded1.38m
  • 1 Year change-7.15%
  • Beta0.4961
Data delayed at least 15 minutes, as of Nov 12 2024 23:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(13)(141)(69)
Depreciation/depletion360339312
Non-Cash items224140199
Cash taxes paid, supplemental108100448
Cash interest paid, supplemental277217133
Changes in working capital(59)20(295)
Total cash from operations406307156
INVESTING
Capital expenditures(102)(96)(223)
Other investing and cash flow items, total24(1862)1,499
Total cash from investing(78)(1959)1,276
FINANCING
Financing cash flow items(7.3)(53)(19)
Total cash dividends paid(150)(142)(130)
Issuance (retirement) of stock, net--00
Issuance (retirement) of debt, net(30)617(31)
Total cash from financing(187)422(179)
NET CHANGE IN CASH
Foreign exchange effects9.80(49)(16)
Net change in cash151(1279)1,238
Net cash-begin balance/reserved for future use6011,879642
Net cash-end balance/reserved for future use7516011,879
SUPPLEMENTAL INCOME
Depreciation, supplemental360339312
Cash interest paid, supplemental277217133
Cash taxes paid, supplemental108100448
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.